ZELTIQ® Aesthetics, Inc. to establish European manufacturing facility in Galway
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that it is establishing a European manufacturing facility in Galway, which is expected to create circa sixty jobs over the next eighteen months.
The U.S.-based company is headquartered in Pleasanton, California, where it also has Research and Development, Finance, Marketing, Manufacturing and Distribution facilities, amongst other support functions. In addition to Manufacturing, ZELTIQ will locate other functions in Galway to support the Manufacturing operations. The company employs over six hundred people on a worldwide basis.
The project is supported by the Department of Jobs, Enterprise & Innovation through IDA Ireland.
Minister for Jobs, Enterprise & Innovation Mary Mitchell O’Connor TD welcoming the announcement said “I am delighted that Galway will benefit from ZELTIQ’s decision to establish its European manufacturing facility with the expected creation of sixty jobs. This is a really exciting development and I very much welcome ZELTIQ to Galway. Ireland already has a dynamic and vibrant Medical Technologies sector and we are keen to expand its footprint into new areas and especially to see it develop further into regional centres. ZELTIQ’s new manufacturing facility and the valuable jobs and economic impact to be created will enhance Ireland’s attractiveness for further similar investments. One of the areas I will be focusing on as Minister is to encourage more job growth in our regions as only a strong economy supporting people at work can pay for services needed to create a fair society. This will ensure a more inclusive prosperity for all. I wish ZELTIQ and its team all the best for the future.”
“With millions of CoolSculpting treatments performed in more than 70 countries around the world, ZELTIQ is firmly establishing itself as a global leader in the noninvasive fat reduction market, which is the fastest growing segment in the aesthetics space,” said Mark Foley, President and CEO of ZELTIQ. “We are very pleased to partner with IDA Ireland at this stage of the company’s growth, invest in Galway, and contribute to the local economy through the creation of new jobs.”
ZELTIQ® Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ’s first commercial product, the CoolSculpting system, is designed to selectively reduce unwanted fat that may not respond to diet or exercise. The CoolSculpting procedure is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed the CoolSculpting procedure to safely, noticeably, and measurably reduce the fat layer.